JAMP-SENNA: Out of Specification
Last updated
Summary
Product
JAMP-SENNA
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
JAMP-SENNA |
SENNA Tablet USP; |
NPN 80009595 |
Tablet |
Cassia angustifolia 8.6mg |
CSJ60920A, CSJ60920AR |
Issue
| The total yeast and mold count is out of specification for the affected lots. |
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers, Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
Jamp Pharma Corporation.
1310 rue Nobel,
Boucherville, Québec,
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-64182
Get notified
Receive notifications for new and updated recalls and alerts by category.